AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Apr 15, 2011
34519_dirs_2011-04-15_b17358f6-7059-4cf0-84bb-71cf265a67d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-02-08
Reporting Person: Kunde Bobbi Jo (Director of Sales & Marketing)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-08 | Incentive Stock Option(Right to Buy) | $3.99 | A | 5000 | Acquired | 2020-02-07 | Common Stock (5000) | Direct |
| 2010-12-15 | Stock Option(Right to Buy) | $3.15 | A | 10000 | Acquired | 2020-12-14 | Common Stock (10000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23